デフォルト表紙
市場調査レポート
商品コード
1671851

非侵襲的出生前検査(NIPT)市場:製品・サービス別、用途別、技術別、期間別、エンドユーザー別、地域別

Non-invasive Prenatal Testing (NIPT) Market, By Product & Service, By Application, By Technology, By Period, By End User, By Geography


出版日
ページ情報
英文 145 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
非侵襲的出生前検査(NIPT)市場:製品・サービス別、用途別、技術別、期間別、エンドユーザー別、地域別
出版日: 2025年02月26日
発行: Coherent Market Insights
ページ情報: 英文 145 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の非侵襲的出生前検査(NIPT)市場は、2025年に50億8,000万米ドルと推定され、2032年には101億5,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率(CAGR)は10.4%で成長すると予測されます。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 50億8,000万米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 10.40% 2032年の価値予測 101億5,000万米ドル
図.非侵襲的出生前検査(NIPT)市場シェア(%)、2025年地域別
Non-invasive Prenatal Testing(NIPT)Market-IMG1

世界の非侵襲的出生前検査(NIPT)市場は、母親の血流中の胎児DNAをスクリーニングし、妊娠中や胎児に侵襲を与えることなく、胎児が遺伝子異常のリスクが高いかどうかを調べるために使用されます。これらの検査は、母親の血流中を循環する胎盤からの無細胞DNA(cfDNA)を分析します。ダウン症、13トリソミー、18トリソミー、性染色体異数性、その他の異常などの遺伝的疾患のリスクを調べることができます。ゲノム技術の進歩に伴い、NIPTは出生前スクリーニングに使用される先駆的技術のひとつとなり、正確な結果を提供し、羊水穿刺のような侵襲的検査に伴う流産のリスクを回避できることから、世界中の妊婦の間で絶大な人気を集めています。

市場力学:

世界の非侵襲的出生前検査(NIPT)市場は、母親の年齢の上昇、ダウン症児の出生率の上昇、NIPTに対する意識の高まり、診断ツールの技術進歩などの要因によって牽引されています。しかし、低所得国では診断サービスへのアクセスが限られており、中絶に関する倫理的問題が市場成長を抑制しています。大きなビジネスチャンスとしては、新興諸国における未開発市場や、遺伝子変異や染色体の微小欠失・重複を検出するNIPTの応用拡大に向けて進行中の研究開発が挙げられます。

本調査の主な特徴

本レポートでは、世界の非侵襲的出生前検査(NIPT)市場を詳細に分析し、2024年を基準年とした予測期間(2025-2032年)の市場規模および複合年間成長率(CAGR%)を掲載しています。

さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する主要考察も提供しています。

世界の非侵襲的出生前検査(NIPT)市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

本調査の対象となる主要企業には、Illumina, Inc.、Natera, Inc.、Roche Diagnostics、Ariosa Diagnostics、Verinata Health, Inc.、Yourgene Health、Centogene N.V.、Eurofins Scientific、F. Hoffmann-La Roche Ltd.、LabCorp、Quest Diagnostics、BGI Genomics、MedGenome Labs、Genetic Technologies Limited、Myriad Genetics, Inc.などがあります。

本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の非侵襲的出生前検査(NIPT)市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。

利害関係者は、世界の非侵襲的出生前検査(NIPT)市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の非侵襲的出生前検査(NIPT)市場、製品・サービス別、2020年~2032年

  • 製品
  • 消耗品
  • アッセイキットおよび試薬
  • 機器
  • サービス

第5章 世界の非侵襲的出生前検査(NIPT)市場、用途別、2020年~2032年

  • トリソミー検出
  • 微小欠失の検出
  • 性染色体異数性の検出

第6章 世界の非侵襲的出生前検査(NIPT)市場、技術別、2020年~2032年

  • 次世代シーケンシング(NGS)
  • ポリメラーゼ連鎖反応(PCR)
  • アレイテクノロジー
  • ローリング円形増幅

第7章 世界の非侵襲的出生前検査(NIPT)市場、期間別、2020年~2032年

  • 0~12週間
  • 13~24週
  • 25~36週

第8章 世界の非侵襲的出生前検査(NIPT)市場、エンドユーザー別、2020年~2032年

  • 病院
  • 診断検査室
  • ホームケア設定
  • その他

第9章 世界の非侵襲的出生前検査(NIPT)市場、地域別、2020年~2032年

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第10章 競合情勢

  • Illumina, Inc.
  • Natera, Inc.
  • Roche Diagnostics
  • Ariosa Diagnostics
  • Verinata Health, Inc.
  • Yourgene Health
  • Centogene N.V.
  • Eurofins Scientific
  • Hoffmann-La Roche Ltd.
  • LabCorp
  • Quest Diagnostics
  • BGI Genomics
  • MedGenome Labs
  • Genetic Technologies Limited
  • Myriad Genetics, Inc.

第11章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫した機会マップ

第12章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI579

Global Non-invasive Prenatal Testing (NIPT) Market is estimated to be valued at US$ 5.08 Bn in 2025 and is expected to reach US$ 10.15 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: US$ 5.08 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 10.40% 2032 Value Projection: US$ 10.15 Bn
Figure. Non-invasive Prenatal Testing (NIPT) Market Share (%), By Region 2025
Non-invasive Prenatal Testing (NIPT) Market - IMG1

Global Non-invasive Prenatal Testing (NIPT) Market is used to screen fetal DNA in the mother's bloodstream to check if the fetus is at a high risk of genetic abnormalities without being invasive to the pregnancy or the fetus. These tests analyze cell-free DNA (cfDNA) from the placenta that circulates in the mother's bloodstream. They can check the risk of genetic conditions like Down's syndrome, Trisomy 13, Trisomy 18, sex chromosome aneuploidies, and other abnormalities. With advancements in genomic technologies, NIPT has become one of the pioneering techniques used for prenatal screening and is gaining immense popularity among expectant mothers worldwide as it provides accurate results and avoids risks of miscarriage associated with invasive tests like amniocentesis.

Market Dynamics:

The global Non-invasive Prenatal Testing (NIPT) market is driven by factors such as increasing maternal age, rising incidence of babies born with Down's syndrome, growing awareness about NIPT, and technological advancements in diagnostic tools. However, limited access to diagnostic services in low-income countries and ethical issues related to abortion restrain market growth. Significant opportunities include untapped markets in developing countries and ongoing R&D to expand applications of NIPT to detect genetic mutations and chromosomal microdeletion or duplications.

Key Features of the Study:

This report provides in-depth analysis of the global Non-invasive Prenatal Testing (NIPT) market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Non-invasive Prenatal Testing (NIPT) market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Illumina, Inc., Natera, Inc., Roche Diagnostics, Ariosa Diagnostics, Verinata Health, Inc., Yourgene Health, Centogene N.V., Eurofins Scientific, F. Hoffmann-La Roche Ltd., LabCorp, Quest Diagnostics, BGI Genomics, MedGenome Labs, Genetic Technologies Limited, and Myriad Genetics, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global Non-invasive Prenatal Testing (NIPT) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Non-invasive Prenatal Testing (NIPT) market

Market Segmentation

  • By Product & Service Insights (Revenue, USD Bn, 2020 - 2032)
    • Product
    • Consumables
    • Assay Kits and Reagents
    • Instruments
    • Services
  • By Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Trisomy Detection
    • Microdeletion Detection
    • Sex Chromosome Aneuploidy Detection
  • By Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • Next-Generation Sequencing (NGS)
    • Polymerase Chain Reaction (PCR)
    • Array Technology
    • Rolling Circular Amplification
  • By Period Insights (Revenue, USD Bn, 2020 - 2032)
    • 0-12 Weeks
    • 13-24 Weeks
    • 25-36 Weeks
  • By End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Diagnostic Laboratories
    • Home Care Settings
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Illumina, Inc.
    • Natera, Inc.
    • Roche Diagnostics
    • Ariosa Diagnostics
    • Verinata Health, Inc.
    • Yourgene Health
    • Centogene N.V.
    • Eurofins Scientific
    • Hoffmann-La Roche Ltd.
    • LabCorp
    • Quest Diagnostics
    • BGI Genomics
    • MedGenome Labs
    • Genetic Technologies Limited
    • Myriad Genetics, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service
    • Global Non-invasive Prenatal Testing (NIPT) Market, By Application
    • Global Non-invasive Prenatal Testing (NIPT) Market, By Technology
    • Global Non-invasive Prenatal Testing (NIPT) Market, By Period
    • Global Non-invasive Prenatal Testing (NIPT) Market, By End User
    • Global Non-invasive Prenatal Testing (NIPT) Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Non-invasive Prenatal Testing (NIPT) Market, By Product & Service, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Product
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Consumables
  • Assay Kits and Reagents
  • Instruments
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Non-invasive Prenatal Testing (NIPT) Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Trisomy Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Microdeletion Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sex Chromosome Aneuploidy Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Non-invasive Prenatal Testing (NIPT) Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Next-Generation Sequencing (NGS)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Array Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Rolling Circular Amplification
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Non-invasive Prenatal Testing (NIPT) Market, By Period, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 0-12 Weeks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 13-24 Weeks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 25-36 Weeks
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Non-invasive Prenatal Testing (NIPT) Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Non-invasive Prenatal Testing (NIPT) Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Period , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Period, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Natera, Inc.
  • Roche Diagnostics
  • Ariosa Diagnostics
  • Verinata Health, Inc.
  • Yourgene Health
  • Centogene N.V.
  • Eurofins Scientific
  • Hoffmann-La Roche Ltd.
  • LabCorp
  • Quest Diagnostics
  • BGI Genomics
  • MedGenome Labs
  • Genetic Technologies Limited
  • Myriad Genetics, Inc.

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us